Literature DB >> 6103463

Measuring Crohn's disease activity.

R F Harvey, M J Bradshaw.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 6103463     DOI: 10.1016/s0140-6736(80)91577-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  40 in total

Review 1.  MRI in Crohn's disease--current and future clinical applications.

Authors:  Gionata Fiorino; Cristiana Bonifacio; Alberto Malesci; Luca Balzarini; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

2.  Body image dissatisfaction in patients with inflammatory bowel disease.

Authors:  Sumona Saha; Ying-Qi Zhao; Samir A Shah; Silvia Degli Esposti; Sheldon Lidofsky; Jason Shapiro; Neal Leleiko; Renee Bright; Meaghan Law; Heather Moniz; Zahid Samad; Marjorie Merrick; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

3.  Narcotic use for inflammatory bowel disease and risk factors during hospitalization.

Authors:  Millie D Long; Edward L Barnes; Hans H Herfarth; Douglas A Drossman
Journal:  Inflamm Bowel Dis       Date:  2011-07-07       Impact factor: 5.325

4.  Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease.

Authors:  Nair Nazareth; Fernando Magro; Elisabete Machado; Teresa Gonçalves Ribeiro; António Martinho; Pedro Rodrigues; Rita Alves; Gonçalo Nuno Macedo; Daniela Gracio; Rosa Coelho; Candida Abreu; Rui Appelberg; Camila Dias; Guilherme Macedo; Tim Bull; Amélia Sarmento
Journal:  Med Microbiol Immunol       Date:  2015-05-21       Impact factor: 3.402

5.  Menstrual cycle changes in women with inflammatory bowel disease: a study from the ocean state Crohn's and colitis area registry.

Authors:  Sumona Saha; Ying-Qi Zhao; Samir A Shah; Silvia Degli Esposti; Sheldon Lidofsky; Sana Salih; Renee Bright; Meaghan Law; Heather Moniz; Nicole Flowers; Marjorie Merrick; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-03       Impact factor: 5.325

Review 6.  Assessment of drug therapy in inflammatory bowel disease.

Authors:  H J Hodgson
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

7.  Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease.

Authors:  Celso L R Belmiro; Heitor S P Souza; Celeste C S Elia; Morgana T L Castelo-Branco; Flavia R Silva; Rosane L Machado; Mauro S G Pavão
Journal:  Int J Colorectal Dis       Date:  2005-01-20       Impact factor: 2.571

8.  Dysmenorrhea in women with Crohn's disease: a case-control study.

Authors:  Sumona Saha; Emilie Midtling; Erica Roberson; Veena A Nair; Arnold Wald; Mark Reichelderfer
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

9.  Infliximab delays but does not avoid the need for surgery in treatment-resistant pediatric Crohn' disease.

Authors:  N A Afzal; A Ozzard; S Keady; M Thomson; S Murch; R Heuschkel
Journal:  Dig Dis Sci       Date:  2007-09-05       Impact factor: 3.199

Review 10.  Deep remission in inflammatory bowel disease: looking beyond symptoms.

Authors:  Camille Zallot; Laurent Peyrin-Biroulet
Journal:  Curr Gastroenterol Rep       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.